Serotonin syndrome as a result of escitalopram and cyclosporin combination in an 84-year-old woman;Syndrome sérotoninergique consécutif à l'association d'escitalopram et de cyclosporine chez une patiente de 84 ans

Revue de Medecine Interne

Volumn 29, Issue 7, 2008, Pages 583-586

  Lang, P O ^a   Hasso, Y ^a   Hilleret, H ^b   Vogt Ferrier, N ^a  

^a Hopital de Geriatrie   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Delirium; Elderly people; Serotonin syndrome

Indexed keywords

CYCLOSPORIN; ESCITALOPRAM;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DELIRIUM; FEMALE; HUMAN; SEROTONIN SYNDROME;

AGED, 80 AND OVER; CITALOPRAM; CYCLOSPORINE; DELIRIUM; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FEVER; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 45849109571     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.12.003     Document Type: Article

References (34)

1. Sternbach H. The serotonin syndrome. Am J Psychiatry 148 (1991) 705-713
2. Dunkley E.J., Isbister G.K., Sibbritt D., Dawson A.H., and Whyte I.M. The Hunter serotonin toxicity criteria: simple and accurate diagnosis rules for serotonin toxicity. QJM 96 (2003) 635-642
3. Boyer E.W., and Shannon M. The serotonin syndrome. N Eng J Med 352 (2005) 1112-1120
4. Wong EH CN, Sze KH, Or KH. Serotonin syndrome in renal transplant patient. J R Soc Med 2002; 95:304-5.
5. Oates J.A., and Sjoerdsma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 10 (1960) 1076-1078
6. Mackay F.J., Dunn N.R., and Mann R.D. Antidepressants and serotonin syndrome in general practice. Br J Gen Pract 49 (1999) 871-874
7. Watson W.A., Litovitz T.L., Rodgers G.C., Klein-Schwartz W., Reid N., Youniss J., et al. 2004 Annual report of the American Association of Poison Control Center Toxic Exposure Surveillance System. Am J Emerg Med 23 (2005) 589-666
8. Reynolds III C.F., Dew M.A., Pollock B.G., Mulsant B.H., Frank E., Miller M.D., et al. Maintenance treatment of major depression in old age. N Engl J Med 354 (2006) 1130-1138
9. Alexopoulos G.S., Katz I.R., Reynolds III C.F., Carpenter D., Docherty J.P., and Ross R.W. Pharmacotherapy of depressive disorders in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract 7 (2001) 361-376
10. Mason P.J., Morris V.A., and Balcezak T.J. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore) 79 (2000) 201-209
11. Lange-Asschenfeldt C., Weigmann H., Hiemke C., and Mann K. Serotonin syndrome as a result of fluoxetine in patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol 22 (2002) 440-441
12. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E., et al. International Union of Pharmacology classification of receptors 5-hydroxytryptamine (serotonin). Pharmocol Rev 46 (1994) 157-203
13. Yuan Y., Tsoi K., and Hunt R.H. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion and confounding?. Am J Med 119 (2006) 719-727
14. van Oekelen D., Megens A., Meert T., Luyten W.H., and Leysen J.E. Functional study of rat 5-HT2A receptors using antisense oligonucleotides. J Neurochem 85 (2003) 1087-1100
15. 2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res 890 (2001) 23-31
16. Parrott A.C. Recreational Ecstasy/MDMA, the serotonin syndrom, and serotonergic neurotoxicity. Pharmacol Biochem Behav 71 (2002) 837-844
17. DeSilva K.E., Le Flore D.B., Marston B.J., and Rimland D. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. AIDS 15 (2001) 1281-1285
18. Giese S.Y., and Neborsky R. Serotonin syndrome: potential consequences of meridia combined with demerol or fentanyl. Plast Reconstr Surg 107 (2001) 293-294
19. Izzo A.A., and Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61 (2001) 2163-2175
20. Turkel S.B., Nadala J.G., and Wincor M.Z. Possible serotonin syndrome in association with 5-HT(3) antagonist agents. Psychosomatics 42 (2001) 258-260
21. Gill M., LoVecchio F., and Selden B. Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 33 (1999) 457-459
22. Lee D.O., and Lee C.D. Serotonin syndrome in child associated with erythromicyn and sertraline. Pharmacotherapy 19 (1999) 894-896
23. Callaway J.C., and Grobs C.S. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse reactions. J Psychoactive Drugs 30 (1998) 367-369
24. Gardner D.M., and Lynd L.D. Sumatriptan contraindications and serotonin syndrome. Ann Pharmacother 32 (1998) 33-38
25. Asch D.A., and Parker R.M. The Libby Zion case: one step forward or two steps back-ward?. N Eng J Med 318 (1988) 771-775
26. Burke W.J., Gergel I., and Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 63 (2002) 331-336
27. Foglia J.P., Pollock B.G., Kirshner M.A., Rosen J., Sweet R., and Mulsant B. Plasma levels of citalopram enantiomers and metabolites in elderly patients. Psychopharmacol Bull 33 (1997) 109-112
28. Preskorn S.H., Shah R., Neff M., Golbeck A.L., and Choi J. The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline. J Psychiatr Pract 13 (2007) 5-12
29. Holmgren P., Carlsonn B., Zackrisson A.L., Lindblom B., Dahl M.L., Scordo M.G., et al. Enantioselective analysis of citalopram and its metabolites in postmoterm blood and genotyping for CYP2D6 and CYP2C19. J Anal Toxicol 28 (2004) 94-104
30. Gutierrez M.M., Rosenberg J., and Abramowitz W. An evaluation of the potential for pharmacokinetic interaction between escitalopram and the cytochrome P450 3A4 inhibitor ritonavir. Clin Ther 25 (2003) 1200-1210
31. Wright D.H., Lake K.D., Bruhn P.S., and Emery Jr. R.W. Nefazodone and cyclosporine drug-drug interaction. J Heart Lung Transplant 18 (1999) 913-915
32. Graudins A., Stearman A., and Chan B. Treatment of serotonin syndrome with cyproheptadine. J Emerg Med 16 (1998) 615-619
33. Roane D.M., Feinberg T.E., Mecker L., Miner C.R., Scicutella A., and Rosenthal R.N. Treatment of dementia-associated agitation with gabapentin. J Neuropsychiatry Clin Neurosci 12 (2000) 40-43
34. Regan W.M., and Gordon S.M. Gabapentin for behavioral agitation in Alzheimer's disease. J Clin Psychopharmacol 17 (1997) 59-60